Fig 1: Impact of EMPA on DEXA-induced changes in hepatic protein and gene expression of NCOA4. (A) Hepatic NCOA4, (B) NCOA4 mRNA expression. Data were expressed as means ± SEM (n = 4). Mean values were compared using one-way ANOVA followed by post hoc Tukey’s multiple comparison test. asignificance vs. CONTROL group, bsignificance vs. DEXA group. DEXA: Dexamethasone, EMPA: Empagliflozin, NCOA4: Nuclear Receptor Coactivator-4.